Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (161-170 of 308) with videos related to

Pageof 31
Sort By:
Leukemia & Lymphoma|February 28, 2007
Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)Bruno C Medeiros, Mark D Minden, Andre C Schuh, et al.
Oncoimmunology|September 30, 2021
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemiaMaria I Edilova, Jaclyn C Law, Safoura Zangiabadi, et al.
Science Translational Medicine|September 17, 2020
B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destructionSujeetha A Rajakumar, Eniko Papp, Kathy K Lee, et al.
Molecular Cancer Research : MCR|August 22, 2022
Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid LeukemiaAlessia Roma, Matthew Tcheng, Nawaz Ahmed, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, et al.
ACS Medicinal Chemistry Letters|November 25, 2014
Nanomolar-Potency Small Molecule Inhibitor of STAT5 ProteinAbbarna A Cumaraswamy, Andrew M Lewis, Mulu Geletu, et al.
Food & Function|June 7, 2021
Structure-activity relationship of avocadyneMatthew Tcheng, Vitor L S Cunha, Nawaz Ahmed, et al.
The Journal of Experimental Medicine|February 10, 2010
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsStefan Gross, Rob A Cairns, Mark D Minden, et al.
Nature Communications|October 25, 2017
Evolution of AF6-RAS association and its implications in mixed-lineage leukemiaMatthew J Smith, Elizabeth Ottoni, Noboru Ishiyama, et al.
Blood|August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemiaCristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
Pageof 31

Showing results (161-170 of 308) with videos related to

Sort By:
Pageof 31
Leukemia & Lymphoma|February 28, 2007
Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)Bruno C Medeiros, Mark D Minden, Andre C Schuh, et al.
Oncoimmunology|September 30, 2021
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemiaMaria I Edilova, Jaclyn C Law, Safoura Zangiabadi, et al.
Science Translational Medicine|September 17, 2020
B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destructionSujeetha A Rajakumar, Eniko Papp, Kathy K Lee, et al.
Molecular Cancer Research : MCR|August 22, 2022
Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid LeukemiaAlessia Roma, Matthew Tcheng, Nawaz Ahmed, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, et al.
ACS Medicinal Chemistry Letters|November 25, 2014
Nanomolar-Potency Small Molecule Inhibitor of STAT5 ProteinAbbarna A Cumaraswamy, Andrew M Lewis, Mulu Geletu, et al.
Food & Function|June 7, 2021
Structure-activity relationship of avocadyneMatthew Tcheng, Vitor L S Cunha, Nawaz Ahmed, et al.
The Journal of Experimental Medicine|February 10, 2010
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsStefan Gross, Rob A Cairns, Mark D Minden, et al.
Nature Communications|October 25, 2017
Evolution of AF6-RAS association and its implications in mixed-lineage leukemiaMatthew J Smith, Elizabeth Ottoni, Noboru Ishiyama, et al.
Blood|August 26, 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemiaCristiana O'Brien, Nirvana Nursimulu, Anit Tyagi, et al.
Pageof 31